AngioDynamics: Discounted Sales Multiple With Real Growth Engines
2025-10-02 15:00:57 ET
Thesis
Last time I looked at AngioDynamics, Inc. (NASDAQ: ANGO ), I rated the stock a Buy . My reasoning was around the fact that the company has a growing set of medical technology products, especially AlphaVac , AngioVac, and NanoKnife, that could bring in more sales and help it grab a bigger share of the market. My main idea was that by shifting focus toward faster-growing areas of healthcare, they could see very strong long-term gains. That said, I also noted there are still some short-term challenges in how well the company can execute its plans which definitely had an impact on its performance....
Read the full article on Seeking Alpha
For further details see:
AngioDynamics: Discounted Sales Multiple With Real Growth Engines
NASDAQ: ANGO
ANGO Trading
0.85% G/L:
$10.665 Last:
110,206 Volume:
$10.62 Open:
